✨
AI Summary
- China's competitive threat and Q3 M&A slowdown discussed.
- New pneumococcal vaccine contender and Spanish biotech strategies explored.
- Shionogi's $2bn acquisition and key biopharma events covered.
More from Citeline Podcasts
